May 2, 2021

Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer

European radiology
Emmanuel Salinas-Miranda, Dominik Deniffel, Xin Dong, Gerard M Healy, Farzad Khalvati, Grainne M O'Kane, Jennifer Knox, Oliver F Bathe, Vickie E Baracos, Steven Gallinger, Masoom A Haider
CONCLUSIONS: Patients with a lower rate of skeletal muscle loss at first follow-up demonstrated improved survival for unresectable PDAC, regardless of their RECISTv1.1-category. Assessing ΔSMI at the first follow-up CT may be useful for prognostication, in addition to routine radiological assessment.